Kannalife, Inc. CEO Recaps 2019 Advances and Potential Ahead
Jotup,
The Companys Chief Executive Officer, Dean Petkanas, commented: 2019 was a milestone year for Kannalife.
The Companys Chief Executive Officer, Dean Petkanas, commented: 2019 was a milestone year for Kannalife.
DOYLESTOWN, Pa., Jan. 28, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a…
/EIN News/ -- DOYLESTOWN, Pa., Jan. 28, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc.
DOYLESTOWN, Pa., Jan. 28, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a…
DOYLESTOWN, Pa., Jan. 28, 2020 (GLOBE NEWSWIRE) -- (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical company…
A recent study revealed research findings around chemotherapy-induced peripheral neuropathy, or CIPN, and the potential for CBD…
(GLOBE NEWSWIRE) -- Kannalife, Inc. (OTC:KLFE), Kannalife (“Kannalife” or “the Company”), a biopharmaceutical company leading…
(GLOBE NEWSWIRE) -- Kannalife, Inc. (KLFE), Kannalife (“Kannalife” or “the Company”), a biopharmaceutical company leading…
Novel Mechanism of Action Studied Comparing Cannabidiol (CBD) and Kannalife's Proprietary CBD-like Molecule Published in the…
(GLOBE NEWSWIRE) -- Kannalife, Inc. (OTC:KLFE), Kannalife ("Kannalife" or "the Company"), a biopharmaceutical company leading…